The feature presentation this month focused on new developments in orthopedics and was led by Gary Bisbee, PhD, the Chairman and CEO of ReGen Biologics, and Brion Umidi, the Company's Senior Vice President and Chief Financial Officer. ReGen is a tissue regeneration company that manufactures and distributed a collagen meniscus implant. Attached is a copy of the presentation with further information on the Company and orthopedic trends.